Substantial improvements to food additives regulatory system are needed
TUESDAY, July 24, 2018 (HealthDay News) — Regulatory changes are needed to address child health concerns related to the use of food additives, according to a policy statement published online July 23 in Pediatrics.
Leonardo Trasande, M.D., M.P.P., from New York University in New York City, and colleagues address emerging child health concerns related to colorings, flavorings, and chemicals added to food during processing and substances used in food contact materials.
The authors note that in the past two decades, concern regarding food additives has increased, partly because of studies documenting endocrine disruption and other adverse effects. Exposure to these chemicals is disproportionate among minority and low-income populations in some cases. For many food additives, regulation and oversight is inadequate because of several key problems in the Federal Food, Drug, and Cosmetic Act. Current requirements for something to be designated as “generally recognized as safe” are not sufficient to ensure the safety of food additives or to protect against conflict of interest. Critical weaknesses exist in the current regulatory system for food additives; data about the health effects of food additives on children are inadequate, although in general, children are more vulnerable to chemical exposures.
“Substantial improvements to the food additives regulatory system are urgently needed, including greatly strengthening or replacing the ‘generally recognized as safe’ determination process, updating the scientific foundation of the FDA’s safety assessment program, retesting all previously approved chemicals, and labeling direct additives with limited or no toxicity data,” the authors write.
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
2009 to 2023 Saw Surge in Probiotic Supplement Use
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk
Docosahexaenoic Acid Supplement Does Not Improve Cognitive Performance
Sugar-Sweetened Beverage, Fruit Juice Intake Linked to Hypertension Risk